Akero Therapeutics, Inc.

NASDAQ:AKRO

48.12 (USD) • At close August 26, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Revenue 000.0040000.284000000000000000000000000
Cost of Revenue 000.0020.0010.0010.0010.0020.0050.0690.0680.0650.0660.0650.0640.0630.060.060.0610000000000000
Gross Profit 000.002-0.001-0.001-0.001-0.002-0.005-0.069-0.068-0.065-0.066-0.065-0.064-0.063-0.06-0.06-0.0610000000000000
Gross Profit Ratio 000.5000-0.007000000000000000000000000
Reseach & Development Expenses 69.25469.56769.29372.23255.32250.6553.39238.63427.98521.78718.3225.08721.36320.51427.71119.4723.97610.60225.70917.37913.0378.79113.13813.8855.964.0631.9831.2538.420.2260.68
General & Administrative Expenses 11.61911.3158.7329.47110.4199.3048.4817.9817.6446.9667.111.0046.2315.5374.7284.8834.994.5264.0744.1593.4173.5883.0832.4241.6491.4490.9850.4740.2420.1950.28
Selling & Marketing Expenses 0000-0.001-0.001-0.002000000000000000000000000
SG&A 11.61911.3158.7329.47110.4189.3038.4797.9817.6446.9667.111.0046.2315.5374.7284.8834.994.5264.0744.1593.4173.5883.0832.4241.6491.4490.9850.4740.2420.1950.28
Other Expenses 0000000000000.24400.0150.0230.0330.0380.0720.13500000000-0.01100
Operating Expenses 80.87380.88278.02581.70365.7459.95361.87146.61535.62928.75325.4236.09127.59426.05132.43924.35328.96615.12829.78321.53816.45412.37916.22116.3097.6095.5122.9681.7278.6620.4210.96
Operating Income -80.873-80.882-78.025-81.703-65.741-59.954-61.873-46.615-35.629-28.753-25.42-36.091-27.594-26.051-32.439-24.353-28.966-15.128-29.783-21.538-16.454-12.379-16.221-16.309-7.609-5.512-2.968-1.727-8.662-0.421-0.96
Operating Income Ratio 00-19,506.25000-217.863000000000000000000000000
Total Other Income Expenses Net 10.36810.1578.0018.9989.7546.616.6876.9564.5462.9222.3610.5490.1910.0220.0150.0230.0330.0380.0720.1350.2470.4930.610.7550.3810.15-58.504-9.421-0.01100
Income Before Tax -70.505-70.725-70.024-72.705-55.987-53.344-55.186-39.659-31.083-25.831-23.059-35.542-27.403-26.029-32.424-24.33-28.933-15.09-29.711-21.403-16.207-11.886-15.611-15.554-7.228-5.362-61.472-11.148-8.673-0.421-0.96
Income Before Tax Ratio 00-17,506000-194.317000000000000000000000000
Income Tax Expense 00000-0.042000-2.465-2.574-0.5490-0.022-0.011-0.051-0.05-0.05-0.011-0.00600-0.04600000000
Net Income -70.505-70.725-70.024-72.705-55.987-53.344-55.186-39.659-31.083-23.366-20.485-34.993-27.403-26.007-32.424-24.33-28.933-15.09-29.711-21.403-16.207-11.886-15.611-15.554-7.228-5.362-61.472-11.148-8.673-0.421-1.026
Net Income Ratio 00-17,506000-194.317000000000000000000000000
EPS -0.86-0.9-0.99-1.05-0.81-0.9-0.99-0.71-0.6-0.5-0.44-0.91-0.77-0.74-0.93-0.7-0.83-0.43-0.86-0.63-0.57-0.42-0.55-0.56-0.27-0.2-2.9-0.53-0.41-0.02-0.041
EPS Diluted -0.86-0.9-0.99-1.05-0.81-0.9-0.99-0.71-0.6-0.5-0.44-0.91-0.77-0.74-0.93-0.7-0.83-0.43-0.86-0.63-0.57-0.42-0.55-0.56-0.27-0.2-2.9-0.53-0.41-0.02-0.041
EBITDA -69.333-69.571-68.809-71.458-54.755-52.352-54.287-38.766-30.157-25.306-22.632-35.152-27.285-25.965-32.428-24.27-28.873-15.117-29.772-21.538-16.454-12.379-16.221-16.309-7.6090.15-2.968-11.148-0.081-0.421-0.066
EBITDA Ratio 00-17,202.25000-191.151000000000000000000000000